Introduction
Both permanent and transient interruptions of blood flow to the heart cause oxidative stress (1) (2) (3) (4) . During hypoxia, and during restoration of oxygen, the production of ROS from both intraand extra-cellular sources increases significantly, including varying proportions of superoxide, hydrogen peroxide, hydroxyl radical, and nitric oxide (5, 6) . Oxidant stress in turn causes myocyte damage and loss, either by direct oxidation of cellular components, or by activation of one or more pathways of programmed cell death (7, 8) . The intrinsic, or mitochondrial, pathway has been implicated in cardiac myocyte death induced by glucose or serum deprivation (9) , overexpression of Gaq (10) and oxidant stress (11) . This pathway is initiated by release of cytochrome c through the outer mitochondrial membrane into the cytosol which catalyzes formation of the apoptosome, a multiprotein complex required for activation of procaspase-9 and effector caspase-dependent cell death (12) (13) (14) . However, the conditions governing formation and composition of the apoptosome in long-lived, essentially non-proliferative cells such as cardiac myocytes remain undefined (8) .
The c-Jun N-terminal kinases (JNKs -1, -2 and -3) are serine/threonine kinases at the terminus of one of the 3-component modules of the mitogenactivated protein (MAP) kinase family (15, 16) JNK isoforms play major roles in development, cell proliferation, cell differentiation, and apoptosis (17) (18) (19) (20) (21) . JNK-1 and JNK-2 are abundant in myocardium and appear to be functionally redundant; JNK-3 is most abundant in brain, where it and JNK-1 play region-specific positive and negative roles in neuronal apoptosis (17, 22) . Studies in mouse embryo fibroblasts suggest that JNK is required for the release of cytochrome c in response to UV irradiation (23) , but dispensable for TNF--induced apoptosis (24) . On the other 2 hand, disruption of MKK4 and MKK7, which prevents JNK activation, had no impact on mitochondria-mediated apoptosis in embryonic stem cells (25) .
Oxidant stress strongly activates JNK1/2 in cardiac myocytes (26, 27) ; however, the significance of this activation, whether in promoting or neutralizing ROS-mediated apoptosis, remains unresolved, and the molecular targets of JNK in this context are unknown. Studies of JNK function in cardiac myocytes (28) (29) (30) (31) (32) (33) (34) and in genetically manipulated mice have also produced conflicting results. Mice deficient in MEKK1, a JNK kinase kinase, displayed enhanced pressure overload-induced apoptosis, suggesting a protective role for JNK (35) . In independent studies, sustained myocardial JNK activation via activated MKK7 caused cardiomyopathy but no increase in apoptosis (36, 37) . In the latter study, low-level JNK activation conferred protection from ischemia-reperfusion injury, but so did deletion of either JNK1 or JNK2, or expression of dominant negative JNK mutants (37) . JNK actions thus appear to be highly context-dependent, and further clarification requires a better understanding of JNK substrates and partners in the apoptotic signalling cascade.
We have previously shown that inhibition of JNK accelerates oxidant-mediated apoptosis in neonatal rat cardiac myocytes (29, 31) . In the present study, we examined the effects and molecular targets of JNK in cardiac myocytes exposed to two distinct physiologic sources of oxidative stress, the nitric oxide donor Snitrosoglutathione (GSNO) and hydrogen peroxide (H 2 O 2 ). JNK inhibition in the presence of either stressor had no effect on cytochrome c release, but accelerated post-mitochondrial apoptotic events, including caspase 9 association with Apaf-1 and activation, both in intact myocytes and in a cellfree system. Oxidant-mediated JNK activation stimulated the formation of a JNK-Apaf-1 complex that excluded active caspase 9. This finding suggests a broad adaptive role for JNK activation in oxidant-rich environments such as the myocardium.
Experimental Procedures
Antibodies -Polyclonal antibodies against caspase-9 and caspase-3 were purchased from Cell Signaling Technology (Beverly, MA). Antibodies against Apaf-1 were obtained from eBioscience (San Diego, CA) and Santa Cruz Biotechnology (Santa Cruz, CA). The latter was also the source for antibodies against caspase-9, JNK (FL), JNK (F3), HA (F-7), normal rabbit and mouse IgGs.
Primary culture of rat neonatal cardiomyocytesAll experiments were conducted under University of Miami Animal Care and Use Committeeapproved protocols. Primary cultures of rat neonatal cardiomyocytes were generated as previously described (38, 39) .
Recombinant Adenovirus Generation and Infection -Construction of the dominant negative JNK1 adenovirus has been previously described (31) . Adenoviruses expressing inactive JNK (JIA) and dominant negative casapase-9 were generated as described by He et al. (40) . The plasmid encoding a dominant negative mutant of rat caspase-9 (C327A) was the gift of Dr. James M. Angelastro (41) . The caspase-9 mutant gene was excised with KpnI and XbaI and inserted into the kanamycinresistant pAdTrack-CMV shuttle vector (Microbix Biosystems Inc., Ontario, Canada). The plasmid encoding inactive JNK protein, a fusion between JNKK2 and JNK1 (APY) was the kind gift of Dr. Anning Lin (42) . All viral vectors were tagged with green fluorescent protein (GFP). Infection with adenoviral vectors was performed overnight at 5 MOI and cells incubated for a further 48 h. Infection efficiency and recombinant protein expression were monitored by GFP expression.
Cell Fractionation and In Vitro Caspase Cleavage Analysis -Cell fractionation analysis was performed as described, with few modifications (43 o C with rotating. Protein A Fast Flow Sepharose (20 μl) was added into the mixtures and incubated overnight. The lysates were centrifuged, after which the supernatants were collected as the unbound fraction. The pellets washed and boiled in 40 μl of 2X SDS sample buffer containing -mercaptoethanol for 5 min. The mixtures were centrifuged and the whole supernatants were loaded onto 10% SDS-PAGE gels for immunoblot analysis using standard methods (39) .
Gel Filtration -Neonatal rat heart ventricles were homogenized in Cell Fractionation Buffer (CFB), incubated on ice for 30 min, and then centrifuged for 15 min at 14000 rpm. Supernatants (cytosolic lysates) were collected and measured for protein concentration. Approximately 2.5 mg of cytosolic lysates (~4 mg/ml) were incubated with or without cytochrome c (10 μM) and ATP (2 mM) for 30 min at 37 o C. Lysates were loaded into 75/16 Sepharose S300 HR gel filtration columns preequilibrated with CFB buffer, and eluted by gravity at flow rate of~0.3 ml/minute. Fractions were collected at an interval of 7 min each, precipitated with trichloroacetic acid (TCA), and run on 10% SDS-PAGE gel for immunoblot analysis.
In vitro caspase activity determination -In vitro colorimetric assays of caspase-9 and caspase-3 activity were performed using a commercially available kit (Caspase-9 or Caspase-3 Colorimetric Assays, R&D Systems, Minneapolis, MN) according to the manufacturer's instructions. Briefly, cells were washed with ice cold PBS and harvested in lysis buffer. Lysates were mixed with chromophore-conjugated caspase-9-or caspase-3-specific substrates (LEHD-pNA or DEVD-pNA, respectively) in 96-well plates, incubated for 1 hour at 37 o C and assayed by measuring the emission wavelength for p-nitroaniline at 405 nm. Caspase activity for each sample was normalized to protein content. Lysates from cells treated with staurosporine (1 M) for 8 h were used as a positive control.
Statistical Analysis -Results were subjected to ANOVA to determine significant inter-group differences, followed by Student t-test (InStat, GraphPad Inc., San Diego, CA). A p value of less than or equal 0.05 was considered significant. Figure 1D ) (44) (45) (46) .
RESULTS

Dominant
Jun kinase delays oxidant-induced caspase-9 activation. We have previously shown that nitric oxide donors induce time-and dose-dependent cardiac myocyte apoptosis through oxidant mechanisms, and that inhibition of Jun kinase accelerates the rate of GSNO-induced DNA fragmentation (29, 39) . Consistent with these observations, we found that NO specifically activated the mitochondria-mediated cell death pathway. GSNO (1 mM) induced caspase-9 activation in a time-dependent manner ( Figure 2A NO-induced cytochrome C release is independent of JNK activity. The selective activation of caspase-9 implicates the type II, mitochondria-mediated pathway in oxidantmediated cardiomyocyte death. Under oxidant stress, mitochondria release cytochrome c, an essential cofactor for the formation of the apoptosome and subsequent activation of caspase-9 (43,47); JNK activation has been implicated in cytochrome c release from mouse embryo fibroblast mitochondria (23) , and from isolated cardiac mitochondria (11) . To assess the effects of JNK activation on cytochrome c release in intact cardiac myocytes, we monitored cytosolic levels of cytochrome c release in cells treated with GSNO in the presence and absence of dnJNK. In uninfected cardiac myocytes, GSNO (1 mM) induced the release of cytochrome c into the cytosol within 10' of treatment; by 5h after treatment, cytosolic cytochrome c levels approached those of control cells ( Figure 3 ). The disappearance of cytochrome C from cytosolic fractions at these time points most likely reflects loss of apoptotic cells from the culture dish; however it is also possible that cytochrome c is taken back up by the mitochondria or otherwise eliminated in surviving cells, as proposed elsewhere (48) . Identical amounts and timing of cytochrome c release were seen in cells infected either with a blank virus (GFP) or Ad-dnJNK. In contrast, overexpression of Bcl-X L delayed cytochrome c release by 12 h (Figure 3 ). These results show that active JNK is not required for initiation of the mitochondrial apoptotic pathway in intact cardiac myocytes, and imply that JNK modulates caspase-9 activation through a postmitochondrial mechanism.
Jun kinase prevents caspase activation in a cell free system. Human caspase-9 contains phosphorylation sites for extracellular-signal regulated kinase (ERK) and Akt (49, 50) , which may also be activated during oxidant stress. To avoid these potentially confounding effects, we examined the effects of JNK activity on caspase-9 and caspase-3 processing in the absence of oxidant stress, using a previously characterized cell-and organelle-free system (43) . Cytosolic extracts of cardiac myocytes and HEK293 cells expressing Ad-GFP or Ad-dnJNK were incubated with or without cytochrome c and ATP, and cleavage of caspase-9 and -3 was monitored by Western analysis. After 3 h of incubation with cytochrome c and ATP, the p37 and p20 cleavage products of caspases -9 and -3 respectively were significantly more abundant in cardiac myocyte cytosol lacking basal JNK activity ( Figures 4A-C) . However, in HEK293 cytosolic lysates, JNK inhibition had no effect on the processing of either caspase-3 or the 5 caspase-3 substrate ICAD (Inhibitor of CaspaseActivated DNAse, Figures 4D-F ). This finding confirms that active JNK interferes with cytosolic caspase-9 activation at a step distal to the mitochondrial release of cytochrome c . Furthermore, this effect appears to be cell typerestricted.
JNK activation retards apoptosome formation. The critical step in activation of procaspase-9 is not proteolytic processing but dimerization, potentiated by enforced aggregation within the apoptosome (12,51-56). Accordingly, we assessed the effect of JNK inhibition on the association of Apaf-1 and caspase-9 in cells under oxidant stress. Complex formation between caspase-9 and Apaf-1 was first detectable 3 h after GSNO stress in uninfected cells or cells expressing a blank vector ( Figure 5 ). In JNK-inhibited cells, caspase-9-Apaf-1 interaction appeared at least 2 hours earlier, i.e., within 1 h after GSNO treatment. This difference corresponds closely to the 2-3h acceleration in caspase-9 induction observed with JNK inhibition (compare Figures 2A and 2B) , and suggests that activation of JNK by oxidant stress may create a several-hour delay in the formation of an active apoptosome.
JNK activation and cytochrome c promote JNK-Apaf-1 interaction. To determine how JNK might affect caspase-9 interaction with Apaf-1, we asked whether JNK itself could bind to apoptosome components. In cells treated with either GSNO or H 2 O 2 , JNK and caspase-9 did not interact (not shown); however, JNK and Apaf-1 were readily and reciprocally coimmunoprecipitated ( Figure 6A ). Oxidant stress strongly potentiated this interaction. Apaf-1-JNK complexes were significantly increased in cytosol from cells treated with GSNO (3.2-fold ±0.82 vs. control, p<0.05) or H 2 O 2 (5.7-fold ±1.21, p<0.05) compared with cytosol from untreated cells ( Figure 6B , lanes 1 and 2; Figure 6C , lanes 1 and 2; and data not shown). This increase was at least partly due to oxidant-stimulated JNK activity, because JNK interaction with Apaf-1 was markedly reduced either by co-expression of dnJNK ( Figure 6B, lanes 3 and 4) or treatment with the JNK inhibitor SP600125 over a 100x range of concentrations ( Figure 6C, lanes 2 and 3) . Consistent with this, the dnJNK mutant protein itself failed to associate with endogenous Apaf-1 ( Fig. 6B and data not shown) . In parallel experiments, adenovirus-mediated overexpression of a wild type JNK1 linked to an inactive JNKK2(KM) (42) had no effect on endogenous JNK activity, and also had no effect on the interaction between endogenous JNK and Apaf-1 (data not shown). Thus, abrogation of the endogenous Apaf1-JNK complex by dnJNK1 was likely attributable to the ability of dnJNK to prevent JNK activation and not to JNK overexpression generally.
The oxidant conditions leading to cellular JNK activation also induce the release of mitochondrial cytochrome c, which promotes the oligomerization of Apaf-1, as well as a number of other signalling events. To study the formation of the Apaf-1-JNK complex in the absence of oxidants, we again utilized an in vitro system in which cytochrome c and ATP or their vehicle were added directly to cytosol purified from unstressed cells. Cytosolic JNK-Apaf-1 interaction increased significantly after addition of cytochrome c (7.5-fold ±1.7 vs. vehicle, p<0.05; Figure 6D , lanes 1 and 2). As with intact cells, inhibition of JNK reduced basal JNK-Apaf-1 interaction ( Figure 6D , lanes 1 and 4) and also completely prevented the cytochrome cmediated increase in this complex (0.8-fold ±0.2 vs. vehicle) ( Figure 6D , lanes 4 and 5). Thus, both cytochrome c and JNK activity regulate the interaction between JNK and Apaf-1, independent of other oxidant-mediated events.
Active JNK associates with oligomerized Apaf-1 and cytochrome c. Cytochrome c could stimulate Apaf-1-JNK binding by promoting a conformation of Apaf-1 with which JNK preferentially associates. To explore this possibility, we assessed the size and composition of the cytochrome c-induced JNK-Apaf-1 complex using size-exclusion chromatography. Cell-free, mitochondria-depleted cytosolic extracts were prepared from normal rat ventricular muscle and incubated with or without exogenous cytochrome c and ATP for 30 min at 37º C. Samples were fractionated by size exclusion chromatography and subjected to Western analysis for Apaf-1, JNK1/2, X-linked inhibitor of apoptosis (XIAP), and cytochrome c. Consistent with previous studies, the majority of Apaf-1 eluted as part of two large 6 multimeric complexes, estimated at 1.4 md and 440-700kd based on the elution of size markers (complexes I and II respectively, Figure 7A ) (51) (52) (53) 57, 58) . Almost all detectable p46JNK, and a small amount of p54JNK, co-eluted with Apaf-1 as part of the larger of these complexes, together with cytochrome c and some p37 caspase-9 (complex I, Figure 7A ). The second, more rapidly eluting complex contained oligomeric Apaf-1 and XIAP and was consistent in size with the active apoptosome (52) . Neither of these complexes was detected in the absence of added cytochrome c/ATP (not shown). Processed caspase-9 (p37) was also detectable in monomeric fractions (III, Figure 7A ). No caspase 3 or DEVDase activity was detected in any fraction ( Figure 7A and data not shown) possibly reflecting the association of XIAP with the 440-700kd complex ( Figure 7A , complex II), as previously reported for nonapoptotic cells (59) .
To determine how JNK activity affected the distribution of these protein complexes, cytosolic lysates were prepared from unstimulated cardiac myocytes expressing Ad-GFP (GFP) or AddnJNK (DNJ), primed briefly (15') with cytochrome c and ATP, and subjected to size fractionation as above. At this early time point, no caspase-3 cleavage or processing activity was detectable in either lysate, and procaspase 3 was exclusively present low mw fractions ( Figure 7E and data not shown). Similar to our findings in myocardial cytosol, exogenous cytochrome c eluted in low mw fractions, possibly complexed with other proteins, and also in oligomeric complexes with Apaf-1 (compare Figures 7A, 7B) . Expression of the JNK inhibitor increased the amount of Apaf-1 present in the 440-700kd complex by 4-5 fold compared with GFP alone ( Figures 7B and C, fractions 32-38) , suggesting an increase in oligomeric Apaf-1. In addition, a band consistent with the 70-80 kd caspase-9 dimer was associated with the smaller Apaf-1 complex only in JNK-inhibited cells (complex II, Figures 7B and  D) . These findings are consistent with a mechanism by which JNK retards the activation of caspase-9 by preventing its association with Apaf-1.
DISCUSSION
We show here that upon activation by oxidant stress, cardiac myocyte JNK forms a stable complex with oligomerized Apaf-1. Association between JNK-Apaf-1 appears to be independent of the upstream events leading to JNK activation. Nitric oxide activates JNK through the cyclic GMP pathway (39) , while reactive oxygen species such as H 2 O 2 induce JNK activation through the MAPKKK ASK1 (60,61) ; nonetheless, both signals induced the formation of this complex.
Although the precise relationship between the JNK-Apaf-1 complex and the canonical apoptosome remains to be elucidated, we also provide evidence that formation of this complex is associated with a delay in assembly of the active apoptosome and in activation of caspase-9. The timing and magnitude of these effects coincide with the peak in JNK activity. Both JNK activation and caspase inhibition are time-limited; however, it is likely that the downstream effects are more sustained. Because caspase-9 is catalytic, changes in its activity are magnified significantly at the level of caspase-3 activation, and more so at the level of terminal substrates such as DNA.
JNK has been shown to modulate mitochondria-dependent apoptosis by phosphorylating members of the Bcl-2 family, which control the release of cytochrome c into the cytosol during apoptosis. Most of these modifications are pro-apoptotic (62) (63) (64) (65) (66) (67) . However, in our system JNK inhibition did not affect the timing of cytochrome c release, arguing against an important effect of JNK on mitochondrial permeability. JNK has been reported to block the pro-apoptotic up-regulation of TNF- (28) , and to potentiate the cytoprotective effects of XIAP in MCF and HEK293 cells (68) . Since apoptosis in our system occurs independently of TNF-, caspase 8 and Bid cleavage, neither of these mechanisms explains JNK cytoprotection in our system (Figure 2A and (39) ). JNK can also act to prevent cell death by transcriptional induction of survival genes, including Jun D and cIAP (24) ; whether transcriptional effects modulate formation of the JNK-Apaf-1 complex remains to be determined. Cell type-or developmental stagespecific factors may also be involved in JNK cytoprotection, since inhibition of JNK did not promote, and may actually have reduced, caspase 7 3 processing and activity in HEK293 cells (see Figures 4D-F) . JNK effects on cell fate are known to be context-dependent (17) (18) (19) (20) (21) (22) 25) .
Sizing chromatography confirmed the association of JNK1/2 and Apaf-1 in a complex with an effective molecular mass of 1.4 -2.0 md, similar to the previously described 1.4md Apaf-1-containing complex in Jurkat T and monocyte cell lysates (51, 57) . In those cells, two Apaf-1-containing complexes of~700 kd and 1.4 md Apaf-1 complexes could associate with caspase-9, but most caspase-processing activity was found in the 700 kd complex (52, 57, 58) . MALDI-TOF spectrometry of the 700 kd complex in THP.1 monocytes identified Apaf-1 and caspase-9 as the major components, with XIAP also present in nonapoptotic cells (59) . Likewise, we found no JNK in the 700kd complex. It has been reported that recombinant Apaf-1 and caspase-9 spontaneously form a >1.3 md complex in the presence of cytochrome c and ATP with a stoichiometry of 1:1 (51) and a heptameric hub-and-spoke structure (14) . Because of limited resolution of the gel filtration columns at high molecular sizes, these studies, like the present one, have not established a precise molecular weight for the larger (1.4-2.0 md) complex, and therefore do not exclude the presence of JNK or other proteins.
Our size fractionation studies further demonstrate that a 46kd protein is the major JNK species in the 1.4 md complex. In fact, almost all of the cytosolic 46kd JNK is found in that complex, while most of the 54kd JNK is found in monomeric fractions. Both p46 and p54 isoforms can arise from alternative splicing of each of the primary JNK transcripts encoded by the JNK-1, -2 and -3 genes; however, JNK-1 appears predominantly as the p46 splice variant, while JNKs 2 and 3 are principally expressed as the p54 variant (69, 70) . Apaf-1 thus appears to associate preferentially with JNK-1. Although JNK-1 and JNK-2 are functionally redundant to some extent, especially during development (17,71), isoformspecific functions for these proteins have been identified in various tissues and cell types (18, 20) . JNK-1 has both pro-and anti-apoptotic actions that depend on context, cell type, duration of activation and co-activation of other signal transduction molecules (72) . JNK-1 is the principal JNK species activated by TNF-, UV exposure and anisomycin (69) and its activation is associated with obesity and onset of diabetes (73) . JNK-1 exhibits both pro-survival and pro-death effects in the brain, where it is the most abundant phospho-JNK species (22) . In glucose-deficient cardiac myocytes, JNK-1 but not JNK-2 mediated oxidative stress-induced apoptosis (30) . On the other hand, suggesting a pro-survival for JNK-1 in the heart, mice with deletion of JNK-1, but not JNK-2, were shown to have impaired adaptation to pressure overload (74) .
These findings suggest that JNK retards the processing and enzymatic activation of caspase-9 in vivo by direct effects at the apoptosome. However, whether JNK has a direct substrate within the apoptosome remains to be determined. Although we find that JNK activity is crucial to induce the interaction with Apaf-1, it may be dispensable thereafter, since none of the JNK within the 1.4md complex appears to be phosphorylated (not shown). Moreover, we have no evidence that JNK is able to phosphorylate Apaf-1; although preliminary evidence indicates that cardiac myocyte Apaf-1 is heavily serinephosphorylated, the abundance of phospho-Apaf-1 is not directly related to JNK activity (data not shown). Sequence analysis of Apaf-1 reveals several consensus docking sites for JNK, and it is possible that the JNK-Apaf-1 interaction provides a scaffold for the recruitment of JNK-associated proteins such as MKK7 and/or MAPK-associated phosphatases that modulate phosphorylation of caspase-9, Apaf-1 or JNK itself. Full identification of the components of the 1.4-2.0 md Apaf-1 complex may shed light on these questions.
Our results also show that in intact, nonstressed myocardium, oligomerized Apaf-1 is extensively bound to XIAP. XIAP provides a major line of defense against accidental or transient cytochrome c release, because it strongly inhibits apoptosome-dependent caspase-9 activation (75, 76) . Some cytoprotective effects of XIAP have been linked to JNK1 activation via TAK1 (77) .
Other factors that inhibit apoptosome-dependent caspase processing include heat-shock protein 70 (HSP70) and 90 (HSP90), protein kinase A, and taurine, a -amino acid (78-8 82 ). HSP90 appears to prevent Apaf-1 oligomerization and interaction with cytochrome c (80) . HSP70 has been reported to bind to Apaf-1 and prevent recruitment of caspase-9 to the apoptosome, without affecting Apaf-1 aggregation (78) . Rather than competing directly with caspase-9 for binding to Apaf-1, Hsp70 may stabilize an inactive Apaf-1 conformation. JNK is required for activation of the hsp70 promoter during heat stress (83), and it is possible that transcriptional induction of Hsp70 could contribute to delayed cytoprotective effects of JNK activation.
JNK activity in cardiac myocytes is dynamic, and sensitive both to cellular redox potential and contractile activity. Transient increases in oxidant stress that occur during periods of increased O 2 demand (such as increased contractile activity), or reduced O 2 supply are potent stimuli for JNK activation (26) . Normal contractile activity and cyclic stretch of myocytes generate significant amounts of ROS and probably account for relatively high basal JNK activity in cardiac myocytes (84, 85) and for the observation that JNK is modulated in vivo in direct relation to cardiac work (86) (87) (88) . The extent of physiologic activation of JNK in the myocardium argues against a simple role in cell death signaling, a view supported by an elegant in vivo study by Kaiser et al (37) . We propose that JNK activation is a physiological adaptation that acts as a buffer against the frequent (but usually transient) bursts of oxidant stress to which the myocardium is exposed. Given that some of the initial steps in oxidant-stimulated, mitochondria-dependent apoptosis may be reversible, including cytochrome c release (89, 90) , the ability of coupled JNK activation to retard the post-mitochondrial phase of apoptosis may be critical to its ability to limit myocyte loss under conditions of increased workload or oxygen deficit. Jun kinase activity has no effect on the rate of NO-induced cytochrome c release. Cardiomyocytes infected with the indicated viruses (Ad--gal ( -Gal), Ad-dnJNK (DNJ), or Ad-Bcl-X L (Bcl-X L )) were treated with GSNO (1 mM) for the indicated times. Samples of cytosolic and mitochondrial fractions were immunoblotted for cytochrome c (Cyt c) and cytochrome c oxidase subunit IV (COX). Graph summarizes densitometric results from 3 independent experiments, with cytosolic cytochrome c density expressed as a percentage of maximum (density at 2h in uninfected cells); representative immunoblots are shown. Cytosol=cytosolic fraction; Mitochondria=mitochondrial fraction. . Figure 4 . Jun kinase inhibits caspase activation in a cell-free system. A-C. JNK inhibits in vitro processing of caspase-9 and -3 in cardiac myocytes. Cytosolic lysates of cardiomyocytes (A-C) infected with adenoviruses expressing GFP, dnJNK (DNJ), or a dominant negative caspase-9 (DNC9) were examined directly, or incubated for three h at 37 o C with or without cytochrome c (10 μM) and ATP (1 mM), and samples (50 g each) immunoblotted as shown. A. Western blot analysis of cardiomyocyte cytosolic caspase-9 (p37, upper) and caspase-3 (p20, lower). B. Quantitation of caspase-9 cleavage product p37, normalized to actin (n=3). C. Quantitation of caspase-3 cleavage product, normalized to actin (n=3). D-F. JNK does not inhibit post-mitochondrial caspase-3 processing in HEK293 cells. D. Western blot analysis of caspase-3 and ICAD cleavage in cytosol of HEK293 cells, before incubation, or after 30' incubation ± cytochrome c and ATP as in (A-C.). Data represent at least 3 individual experiments. E. Densitometry measurements of caspase-3 p20 cleavage product. F. ICAD cleavage densitometry. Band intensities were normalized as in (B-C). *p<0.05. ProCasp9 = procaspase 9. Casp3 p20 = caspase 3 cleavage product. Figure 5 . JNK inhibition accelerates association of Apaf-1 and caspase-9 after oxidant stress. The interaction of caspase-9 and Apaf-1 was monitored in control cardiomyocytes, or cardiomyocytes infected with Ad--gal ( -Gal) or Ad-dnJNK (DNJ) (see Methods). Total cell lysates were prepared from 13 cardiomyocytes after treatment with GSNO (1 mM) for the indicated times. A portion of the lysates was immunoprecipitated with antibody against caspase-9, and immunoblotted for Apaf-1. The remaining total cell lysates were immunoblotted for total caspase-9 and Apaf-1. (Upper panel) Representative immunoblots for caspase-9 immunoprecipitates and total cell lysates at the indicated times after GSNO treatment. (Lower panel) Dnsitometric analysis of caspase-9-complexed Apaf-1 (n=3) normalized to total Apaf-1 (n = 3, **p<0.05). Fraction numbers E.
158 kd 67 kd 158 kd 67 kd Figure 7 . Tran et al.
